Twist Bioscience Scheduled to Report Q4 2026 Earnings on November 12
Twist Bioscience (TWST) is set to release its fourth-quarter earnings results on Thursday, November 12, prior to the market opening. Investors are closely watching for performance metrics against consensus estimates as the company continues its growth trajectory. Market analysts have established a consensus EPS estimate of -$0.20 and a revenue projection of $123.63 million. The latter represents a significant year-over-year increase of 24.9%, highlighting strong top-line momentum for the biotechnology firm.
Tickers: $TWST
Topics: earnings announcement EPS estimates revenue estimates